RESTRUCTURING (Detail Textuals) (Facility Elimination, USD $)	3 Months Ended	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2013
Surgical products | Selling, general and administrative expense
Restructuring Cost and Reserve [Line Items]
Operational transition expenses	$ 157,000	$ 250,000
Scenario, Forecast
Restructuring Cost and Reserve [Line Items]
Description of restructuring plan		On May 8, 2013, our Board of Directors approved a restructuring of our vascular access manufacturing operations.
Scenario, Forecast | Maximum
Restructuring Cost and Reserve [Line Items]
Incremental expenses		4,100,000
Capital expenditures		2,700,000
Scenario, Forecast | Minimum
Restructuring Cost and Reserve [Line Items]
Incremental expenses		3,700,000
Capital expenditures		$ 2,500,000